Alnylam Pharmaceuticals (ALNY) Intangibles (2009 - 2012)
Alnylam Pharmaceuticals' Intangibles was $145,000 in Q3 2012, down 54.4% from $318,000 a year earlier and down 22.9% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Intangibles (2009 - 2012) Analysis & Trends
At the end of FY2011, Intangibles at Alnylam Pharmaceuticals came in at $275,000, down 38.6% from FY2010.
- In earlier years, Intangibles was $448,000 in FY2010 (-28.0%) and $622,000 in FY2009.
- The Q3 2012 figure marks the lowest quarterly Intangibles in data going back to Q4 2009.
- Compared with a year earlier, Intangibles has declined for six straight quarters, with an average decline of 39.9% over the last seven quarters.
- Per Business Quant data, ALNY's Intangibles in the three quarters before Q3 2012 was $188,000 (Q2 2012), $231,000 (Q1 2012) and $275,000 (Q4 2011).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2012 | 145,000.00 |
| Jun 30, 2012 | 188,000.00 |
| Mar 31, 2012 | 231,000.00 |
| Dec 31, 2011 | 275,000.00 |
| Sep 30, 2011 | 318,000.00 |
| Jun 30, 2011 | 361,000.00 |
| Mar 31, 2011 | 405,000.00 |
| Dec 31, 2010 | 448,000.00 |
| Sep 30, 2010 | 491,000.00 |
| Jun 30, 2010 | 535,000.00 |
| Dec 31, 2009 | 622,000.00 |
API Access
Alnylam Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();